Somaxon Pharmaceuticals Inc. v. Actavis Elizabeth LLC
| PROCOM ONE INC., CURRAX HOLDINGS LLC, SOMAXON PHARMACEUTICALS INC., CURRAX HOLDINGS USA LLC and CURRAX PHARMACEUTICALS LLC |
| ACTAVIS INC., ACTAVIS ELIZABETH LLC, MYLAN INC. and MYLAN PHARMACEUTICALS INC. |
| 20-2074 |
| July 28, 2020 |
| U.S. Court of Appeals, Federal Circuit |
| Other |
Docket Report
RSS Track this Docket
This docket was last retrieved on September 21, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 16 REPLY of Appellees Mylan Inc. and Mylan Pharmaceuticals Inc. to response [ # 15 ]. Service: 09/21/2020 by email. [723378] [20-2074] [Nicole Stafford] [Entered: 09/21/2020 06:55 PM] |
| Filing 15 RESPONSE of Appellants Currax Holdings LLC, Currax Holdings USA LLC, Currax Pharmaceuticals LLC and Somaxon Pharmaceuticals Inc. to the motion to terminate appeal [ # 12 ]. Service: 09/16/2020 by email. [722245] [20-2074] [Dominick Conde] [Entered: 09/16/2020 04:33 PM] |
| Filing 14 Notice of Correction to Doc No. [ # 13 ] for Appellants Currax Holdings LLC, Currax Holdings USA LLC, Currax Pharmaceuticals LLC and Somaxon Pharmaceuticals Inc.. Service: 09/16/2020 by email. [722231] [20-2074] [Dominick Conde] [Entered: 09/16/2020 04:23 PM] |
| Filing 13 RESPONSE of Appellants Currax Holdings LLC, Currax Holdings USA LLC, Currax Pharmaceuticals LLC and Somaxon Pharmaceuticals Inc. to the motion to terminate appeal [ # 12 ]. Service: 09/14/2020 by email. [721456] [20-2074] [Dominick Conde] [Entered: 09/14/2020 05:22 PM] |
| Filing 12 MOTION of Appellees Mylan Inc. and Mylan Pharmaceuticals Inc. to terminate appeal through Dismissal. Cases to be terminated: 20-2074. (Briefing suspended pursuant to FCR 31 pending resolution of the motion). [Consent: opposed]. Service: 09/04/2020 by email. [719859] [20-2074] [David Steuer] [Entered: 09/04/2020 07:11 PM] |
| Filing 11 NOTICE OF NON-COMPLIANCE: The submission of Appellees Mylan Inc. and Mylan Pharmaceuticals Inc., Motion to Dismiss Appeal [ # 10 ], is not in compliance with the rules of this court (see attached). Compliant document due on 09/14/2020. Service as of this date by the Clerk of Court. [719741] [KMH] [Entered: 09/04/2020 03:02 PM] |
| Filing 10 MOTION of Appellee Mylan Inc. to terminate appeal through Dismissal. Cases to be terminated: 20-2074. (Briefing suspended pursuant to FCR 31 pending resolution of the motion). [Consent: opposed]. Service: 09/02/2020 by email. [719283] [20-2074] This document is non-compliant. See Doc No. [ # 11 ] [David Steuer] [Entered: 09/02/2020 10:37 PM] |
| Filing 9 Notice to Appellant Procom One Inc. and Appellees Actavis Elizabeth LLC and Actavis Inc.: The record of this case indicates that no Entry of Appearance under FCR 47.3(b), Certificate of Interest under FCR 47.4, or Docketing Statement under FCR 33.1(a) have been filed. Failure to file required documents may result in adverse action. See FCR 25(h). Service as of this date by the Clerk of Court. [716419] [KMH] [Entered: 08/21/2020 08:53 AM] |
| Filing 8 Docketing Statement for the Appellees Mylan Inc. and Mylan Pharmaceuticals Inc.. Service: 08/12/2020 by email. [714422] [20-2074] [David Steuer] [Entered: 08/12/2020 01:19 PM] |
| Filing 7 Official caption revised to add parties. (see attached). Service as of this date by the Clerk of Court. [714358] [KMH] [Entered: 08/12/2020 09:47 AM] |
| Filing 6 Certificate of Interest for Mylan Inc.; Mylan Pharmaceuticals, Inc.. Service: 08/11/2020 by email. [714295] [20-2074] [David Steuer] [Entered: 08/11/2020 06:11 PM] |
| Filing 5 Entry of appearance for David S. Steuer as counsel for Mylan Inc.; Mylan Pharmaceuticals, Inc.. Service: 08/11/2020 by email. [714294] [20-2074] [David Steuer] [Entered: 08/11/2020 06:03 PM] |
| Filing 4 Docketing Statement for the Appellants Currax Holdings LLC, Currax Holdings USA LLC, Currax Pharmaceuticals LLC and Somaxon Pharmaceuticals Inc.. Service: 08/11/2020 by email. [714242] [20-2074] [Dominick Conde] [Entered: 08/11/2020 03:30 PM] |
| Filing 3 Certificate of Interest for Appellants Currax Holdings LLC, Currax Holdings USA LLC, Currax Pharmaceuticals LLC and Somaxon Pharmaceuticals Inc.. Service: 08/11/2020 by email. [714241] [20-2074] [Dominick Conde] [Entered: 08/11/2020 03:26 PM] |
| Filing 2 Entry of appearance for Dominick A. Conde; Christopher P. Borello; Joshua D. Calabro as counsel for Appellants Currax Holdings LLC, Currax Holdings USA LLC, Currax Pharmaceuticals LLC and Somaxon Pharmaceuticals Inc.. Service: 08/11/2020 by email. [714239] [20-2074] [Dominick Conde] [Entered: 08/11/2020 03:24 PM] |
| Filing 1 Appeal docketed. Received: 07/24/2020. [710509] Entry of Appearance is due on 08/11/2020. Certificate of Interest is due on 08/11/2020. Docketing Statement is due on 08/11/2020. Appellant's brief is due on 09/28/2020. [KMH] [Entered: 07/28/2020 09:23 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
